STOCKS NEWS EUROPE-Silence Thera falls on lack of deal news
STOCKS NEWS Reuters Results diary
Europe [STXNEWS/EU] Real-time Equity News [E] [GB/EQUITY]
11:37GMT 01Apr2009-Silence Therapepeutics falls on lack of deal news
--------------------------------------------------------------------
Shares in gene company Silence Therapeutics (SLN.L) fall 10.9 percent as investors were disappointed that there were no new announcements on licence deal progress alongside the full year results.
"I think it's just a little bit of disappointment that there's not more of an insight into what deals could be achieved," says Matrix analyst Navid Malik.
Nomura, which has a 'buy' on the stock, says: "We had expected more AstraZeneca-like deals to be completed in 2008 and continue to expect them in 2009."
To see Silence Therapeutics' statement please click on [ID:nPRrV473Da]
Reuters messaging rm://ben.deighton.thomsonreuters.com@reuters.net
11:27GMT 01Apr2009-HSBC firms as nil-paid rights nears end
----------------------------------------------------------
Shares in HSBC (HSBA.L) rise 3.3 percent as the last day of trading for its nil-paid rights related to its record 12.9 billion pound fundraising lends support, dealers say.
HSBC's nil-paid rights shares HSBAn.L rose 9.2 percent to 154.5 pence apiece as the London listed shares rise to 408 pence aided by short-covering of positions, dealers say. The new shares are being offered to investors at 254 pence each, representing a 38 percent discount to the current price.
HSBC has largely avoided the troubles faced by other UK bank rights issues last year, and take-up for its offer is expected to exceed 90 percent. Continued...
